Just noticed CSL has just written off their heart attack drug which cost $ 1 billion over 9 years of development. The drug is a protein ApoA-1 that was extracted from spent plasma and was to be applied after someone had a heart attack and was supposed to limit the risk of another heart attack or stroke.
Maybe AGN is now in CSL's cross hairs.
Ann: Phase 2 Manufacturing Completed & Trial Update, page-6
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
68.0¢ |
Change
-0.005(0.73%) |
Mkt cap ! $87.10M | |||
| Open | High | Low | Value | Volume |
| 68.0¢ | 69.0¢ | 66.5¢ | $77.03K | 113.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3112 | 68.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 69.0¢ | 1500 | 1 |
View Market Depth
| Last trade - 15.41pm 02/10/2024 (20 minute delay) ? |
| AGN (ASX) Chart |